Tag: Alkem Laboratories
Alkem Laboratories signs licensing agreement with Takeda to launch Vonoprazan in...
Vonoprazan, a novel treatment for GERD and other gastric conditions, will be marketed by Alkem Laboratories under the brand name "Vonzai"
World Asthma Day: Alkem Labs collaborates with 100 hospitals in Tier-1...
The initiative seeks to educate patients, healthcare professionals, & the general public about the benefits of controller medications in preventing asthma symptoms & reducing the need for rescue medication
World COPD Day: Alkem Healthy Lungs Initiative promotes importance of inhalation...
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Alkem Laboratories forays into Ophthalmology with launch of eye care products
Alkem introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment
Alkem Laboratories to launch unique patented technology for diabetic foot ulcer
This technology will be available at affordable rates to Indian patients at a time when there is no definitive treatment for DFU in India
Alkem Laboratories launches lung care division ‘Pulmocare’ to enhance lung disease...
The initiative aims to enhance awareness, diagnosis and management for lung diseases like asthma, COPD, allergy, advanced lung diseases and lung infections.........................